These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6105788)

  • 1. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
    Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
    Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance?
    Naber D; Fischer H; Ackenheil M
    Commun Psychopharmacol; 1979; 3(1):59-65. PubMed ID: 38032
    [No Abstract]   [Full Text] [Related]  

  • 4. The pituitary dopamine receptor.
    Labrie F; Di Paolo T; Raymond V; Ferland L; Beaulieu M
    Adv Biochem Psychopharmacol; 1980; 23():217-27. PubMed ID: 6104906
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
    Delitala G; Stubbs WA; Yeo T; Jones A; Thorner MO; Besser GM
    J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
    Meltzer HY; So R; Fang VS
    Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of prolactin secretion: a mini-review.
    Slaunwhite WR
    Prog Clin Biol Res; 1981; 75B():19-29. PubMed ID: 6275411
    [No Abstract]   [Full Text] [Related]  

  • 8. Tachykinins and the control of prolactin secretion.
    Debeljuk L; Lasaga M
    Peptides; 2006 Nov; 27(11):3007-19. PubMed ID: 16930771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
    Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
    Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
    Wiggins JF; Sved AF; Fernstrom JD
    J Pharmacol Exp Ther; 1980 Feb; 212(2):304-8. PubMed ID: 6766188
    [No Abstract]   [Full Text] [Related]  

  • 11. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
    Holt RI
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [[Dopamine receptor; characterization of D-2 receptor in the intermediate lobe of the pituitary gland (author's transl)].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1600-8. PubMed ID: 6272362
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine, PIF, and other regulators of prolactin secretion.
    Clemens JA; Shaar CJ; Smalstig EB
    Fed Proc; 1980 Sep; 39(11):2907-11. PubMed ID: 6105975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
    Braghiroli L; Ponzianelli A; Mazzanti G
    Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of yohimbine on rat prolactin secretion.
    Meltzer HY; Simonovic M; Gudelsky GA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.